Key points
- Pharmacovigilance systems must operate under a defined and controlled document framework.
- All documents must be created, reviewed, approved, version-controlled, and archived in a structured manner.
- Controlled documents must reflect current regulatory requirements and operational practice.
- Access to documents must be managed to ensure use of current approved versions only.
- Changes to documents must be controlled, documented, and traceable.
- Inspection-ready evidence must demonstrate that document control processes are implemented and effective.
What inspectors expect
Each point below should be supported by controlled documents and traceable records.
- All PV documents must be controlled and maintained within a structured system.
- Only current approved documents must be in use.
- Document changes must be traceable and approved.
- Access to documents must be controlled.
- Document control must support compliance and inspection readiness.
Summary
Inspectors assess whether pharmacovigilance systems operate under a controlled document framework. They review how documents are created, approved, versioned, distributed, updated, and archived, and whether only current approved documents are in use across the organisation. Document control must operate as a continuous lifecycle, ensuring documents are created, approved, used, reviewed, updated, and archived in a controlled and traceable manner.
Common questions
These are the questions this page is designed to answer directly.
- What is document control in pharmacovigilance?
- What do inspectors check for PV document control?
- What is a controlled document system in PV?
- How are SOPs managed in pharmacovigilance?
- What is required for document control under GVP?
- How do you maintain document control in PV systems?
- What documents must be controlled in pharmacovigilance?
- What is a document control framework?
- How do regulators assess document control systems?
- What is required for inspection-ready documentation?
Evidence objects inspectors expect
Document Control SOP
- Defined document lifecycle from creation to archiving
- Responsibilities for document ownership and approval
- Version control and numbering rules
- Distribution and access control requirements
Controlled Document Master List
- List of all controlled documents
- Current version numbers and effective dates
- Document owners and approvers
- Status of documents (active, obsolete, under review)
Document Templates
- Standard SOP template
- Work instruction template
- Consistent formatting and structure requirements
- Defined document headers, numbering, and version control
Document Access and Distribution Controls
- Access control to document management systems
- Controlled distribution of approved documents
- Prevention of use of obsolete or uncontrolled copies
- User permissions and audit trail of access
Document Lifecycle and Governance Evidence
- Evidence of document review and approval workflows
- Document revision history logs
- Governance records confirming document updates
- Evidence of document updates following regulatory changes
Regulatory Basis (Primary Sources)
- GVP Module I – requirement for a quality system including document control
- GVP Module II – pharmacovigilance system master file and documentation requirements
- ICH E2D – requirement for structured and controlled safety data management processes
- MHRA GPvP guidance – expectations for controlled documentation
- FDA 21 CFR Part 11 – requirements for electronic records and document control
Typical Inspection Questions (What Inspectors Ask)
- How do you control pharmacovigilance documents?
- How do you ensure only current documents are in use?
- Show me your document master list.
- How are document changes managed?
- How do you prevent use of obsolete documents?
Failure patterns
Documents are used without formal approval or version control.
Obsolete documents remain in use across the organisation.
Document ownership and responsibilities are unclear.
Changes are made without formal change control.
Document lists are incomplete or not maintained.
What good looks like
- A defined document control framework covering the full lifecycle.
- A complete and current master document list.
- Controlled templates ensuring consistency of documentation.
- Clear access control and prevention of obsolete document use.
- Traceable document changes and governance oversight.
Operationalisation
- Define document control processes within a PV SOP.
- Maintain a controlled document master list.
- Use standardised templates for all PV documents.
- Implement access controls for document systems.
- Ensure all document changes are reviewed and approved.
- Monitor document compliance through governance and audits.
Need regulatory documentation today?
Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.
Related pre-built documentation inside the app
FAQ
What is document control in pharmacovigilance?
Document control is the process of managing documents through their lifecycle to ensure they are accurate, approved, current, and compliant with regulatory requirements.
What documents must be controlled in pharmacovigilance?
All SOPs, work instructions, forms, templates, reports, and records related to pharmacovigilance activities must be controlled.
How do inspectors assess document control systems?
Inspectors review document lists, approval records, version control, access controls, and evidence that only current documents are in use.
Why is document control important in pharmacovigilance?
Document control ensures that processes are consistent, compliant, and traceable, supporting inspection readiness and regulatory compliance.
What is a controlled document?
A controlled document is a document that has been formally reviewed, approved, versioned, and managed within a document control system.
How do you prevent use of outdated documents?
Outdated documents are controlled through versioning, access restrictions, removal from circulation, and clear marking as obsolete.
Sources
Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.
European Medicines Agency (EMA)
- Guideline on good pharmacovigilance practices (GVP) – Module IView source
- Guideline on good pharmacovigilance practices (GVP) – Module IIView source
FDA
- 21 CFR Part 11 – Electronic RecordsView source
ICH
- Post-Approval Safety Data Management (E2D)View source
MHRA
- Good Pharmacovigilance Practice (GPvP)View source